Home > Insider Trading > Filing (0001209191-19-036764)

Filing Details

Accession Number:: 0001209191-19-036764
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2019-06-13 16:16:00
Reporting Period:: 2019-06-11

Accepted Time:: 2019-06-13 16:16:00
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1645113	Novocure Ltd	NVCR	Surgical & Medical Instruments & Apparatus (3841)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1654435	Asaf Danziger	C/O Novocure Inc. 20 Valley Stream Parkway, Suite 300 Malvern PA 19355	Chief Executive Officer	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Ordinary Shares	Acquisiton	2019-06-11	16,835	$14.37	275,146	No	4	M	Direct
Ordinary Shares	Disposition	2019-06-11	15,985	$54.71	259,161	No	4	S	Direct
Ordinary Shares	Disposition	2019-06-11	850	$55.43	258,311	No	4	S	Direct
Ordinary Shares	Acquisiton	2019-06-12	30,436	$14.37	288,747	No	4	M	Direct
Ordinary Shares	Disposition	2019-06-12	12,233	$54.89	276,514	No	4	S	Direct
Ordinary Shares	Disposition	2019-06-12	18,203	$55.74	258,311	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Ordinary Shares	Options to Buy Ordinary Shares	Disposition	2019-06-11	16,835	$0.00	16,835	$14.37
Ordinary Shares	Options to Buy Ordinary Shares	Disposition	2019-06-12	30,436	$0.00	30,436	$14.37

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
220,774		2025-02-23	No	4	M	Direct
190,338		2025-02-23	No	4	M	Direct

Footnotes

Transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Mr. Danziger.
On June 11, 2019, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Danziger, Mr. Danziger sold 15,985 shares in multiple trades at prices ranging from $54.37 to $55.35. The price reported above reflects the weighted average sale price. Mr. Danziger hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.
On June 11, 2019, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Danziger, Mr. Danziger sold 850 shares in multiple trades at prices ranging from $55.41 to $55.45. The price reported above reflects the weighted average sale price. Mr. Danziger hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.
On June 12, 2019, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Danziger, Mr. Danziger sold 12,233 shares in multiple trades at prices ranging from $54.39 to $55.38. The price reported above reflects the weighted average sale price. Mr. Danziger hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.
On June 12, 2019, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Danziger, Mr. Danziger sold 18,203 shares in multiple trades at prices ranging from $55.40 to $56.10. The price reported above reflects the weighted average sale price. Mr. Danziger hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.
Fully vested and currently exercisable as of the date hereof.